In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model
- 8 May 2019
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 36 (2) , 323-333
Abstract
Organophosphorus nerve agents (NAs) irreversibly inhibit acetylcholinesterase, which results in the accumulation of acetylcholine and widespread excitotoxic seizure activity. Because current medical countermeasures (anticholinergics, AChE reactivators, and benzodiazepines) lack sufficient anti-seizure efficacy when treatment is delayed, those intoxicated are at risk for severe brain damage or death if treatment is not immediately available. Toward developing a more effective anti-seizure treatment for NA intoxication, this study evaluated the efficacy of A1 adenosine (ADO) receptor (A1AR) agonists in a rat soman seizure model. One minute after exposure to soman (1.6 × LD50, subcutaneous), rats were treated intraperitoneally with one of the following agonists at increasing dose levels until anti-seizure efficacy was achieved: N6-cyclopentaladenosine (CPA), 2-chloro-N6-cyclopentyladenosine (CCPA), and (±)-5'-chloro-5′-deoxy-ENBA (ENBA). All A1AR agonists were efficacious in preventing seizure and promoting survival. The effective doses for the A1AR agonists were 60 mg/kg CPA, 36 mg/kg CCPA, and 62 mg/kg ENBA. Whereas vehicle-treated rats experienced 100% seizure and 21% survival (N = 28), ADO treatments reduced seizure occurrence and improved survival rates: 8% seizure and 83% survival with CPA (60 mg/kg, N = 12), 17% seizure and 75% survival with CCPA (36 mg/kg, N = 12), and 8% seizure, 83% survival with ENBA (62 mg/kg, N = 12). The brains of ADO-treated rats were also protected from damage as indicated by neurohistopathological analysis. While all ADO agonists provided neuroprotection, rats receiving CCPA and ENBA experienced less severe ADO-induced side effects (e.g., sedation, hypothermia, bradycardia) than with CPA. The data from this study suggest that the ADO signaling pathway is a promising mechanism for countering seizure activity induced by NAs.Keywords
Funding Information
- National Institutes of Health (AOD16024-001-00000/A120-B.P2016-02)
This publication has 22 references indexed in Scilit:
- Respiratory Complications of Organophosphorus Nerve Agent and Insecticide Poisoning. Implications for Respiratory and Critical CareAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Adenosine Augmentation Therapy2012
- Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigsDrug and Chemical Toxicology, 2010
- The Role of Diazepam in the Treatment of Nerve Agent Poisoning in a Civilian PopulationToxicological Reviews, 2004
- Cardiovascular effects of the adenosine A1 receptor agonist N 6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoningArchives of Toxicology, 2003
- Adenosine A1 Receptor Agonist N6-Cyclopentyladenosine Affects the Inactivation of Acetylcholinesterase in Blood and Brain by SarinThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Therapeutic efficacy of the adenosine A 1 receptor agonist N 6 -cyclopentyladenosine (CPA) against organophosphate intoxicationArchives of Toxicology, 2002
- The Role and Regulation of Adenosine in the Central Nervous SystemAnnual Review of Neuroscience, 2001
- Tissue distribution of adenosine receptor mRNAs in the ratBritish Journal of Pharmacology, 1996
- Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation.Hypertension, 1992